🔥Prime Editing is not only
🎖️the most promising genome editing technology for basic research,
⚕️It packs the power to rewrite the fate of inherited diseases.
Hosted by Paula Rio next September 1-2, we are celebrating a practical course on Prime Editing at CIEMAT, in Madrid
🚨Last Week, 17 trainees from al over Europe participated in our most recent @genehumdi training School in Madrid. They have now the tools and skills to rewrite the future of gene medicine! Learn more in our post:genehumdi.eu/successful-prim…
🌟@genehumdi colleagues just published a paper on how to make #CRISPR tools useful for human disorders by studying the best delivery strategies to maximize each tool according to the biological target in the body.
Open article: ijbs.com/v22p6539.htm#GenomeEditing#GeneTherapy
⚠️ Have you hear about Prime Editing Tools that allow to rewrite mutations into healthy genes?
🔬 @GeneHumdi is organizing a Free Training School to teach the skills needed to work in therapeutic Prime Editing!
🔎 Check the program and trainers line out genehumdi.eu/prime-editing-i…
🏥 The Training School will be held at CIEMAT in Madrid , September 1 & 2
✒️ Registration is needed.
💶 Economic support is available for limited eligible trainees.
Please, visit genehumdi.eu/prime-editing-i… for more info on how to apply before July 14th!
🔥Prime Editing is not only
🎖️the most promising genome editing technology for basic research,
⚕️It packs the power to rewrite the fate of inherited diseases.
Hosted by Paula Rio next September 1-2, we are celebrating a practical course on Prime Editing at CIEMAT, in Madrid
🔥Prime Editing is not only
🎖️the most promising genome editing technology for basic research,
⚕️It packs the power to rewrite the fate of inherited diseases.
Hosted by Paula Rio next September 1-2, we are celebrating a practical course on Prime Editing at CIEMAT, in Madrid
Participation is free for all selected trainees.
We encourage the participation of Young Researchers, specially form ITC countries. GenE-HumDi COST Action CA21113 will provide financial support for travel and accommodation for selected trainees.
If you want to learn more about therapeutic genome editing using Prime Editing tools and how to apply for enrollment or funding check our website.
COST Action is an EU funded network.
genehumdi.eu/prime-editing-i…
🌍 The GeneHumdi Annual Meeting 2026 brought together leading international experts in genome editing, advanced therapies and translational biomedicine at GENYO, in Granada, from May 26th to 28th. @genyo_ptsinstagram.com/reel/DZmijcaMG…
1/4🔬Excited to announce the COST-funded Virtual Conference on “Lipid Nanoparticles: From Fundamentals to Targeted Delivery”.
Submit you abstract for flash presentations on lipid nanoparticles, RNA delivery, nanomedicine, and targeted therapeutics.
3/4
With the support and collaboration of:
Dr. Maria Cristina Vinci, Cardiovascular Epigenetics Lab, Milan, Italy.
Dr. Claudio Mussolino, Genome & Epigenome Engineering Lab, Freiburg, Germany.
Cecilia Jimenez presented #EGMEDC, a new initiative to foster communication and exchange between #Genomeediting Clinicians, Healthcare Institutions and regulatory keyholders.
at the @GeneHumdi#Granada2026#AnnualMeeting Gloria Gonzalez-Aseguinolaza @ggasegui Invited GenE-HumDi members to join the @ESGCT and offered to provide forums to keep and extend the collaborative networks started by our Action.
Jennifer Stott @idtdna opened the second session presenting: "From Target Discovery to Treatment: How IDT is Enabling CRISPR Medicine" showcasing a thorough toolkit to help #GenomeEditing